Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Campbell Rogers

Chief Medical Officer at Heartflow, Inc. (HTFL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.7M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 21SEC HTFLHeartflow, Inc. Sell Plan 19,68279,956 held (−20%) $50.15 $987K -0.8%
Aug 19SEC HTFLHeartflow, Inc. Sell Plan 9,21986,459 held (−10%) $41.23 $380K +20.6%
Jul 17SEC HTFLHeartflow, Inc. Sell Plan 9,21988,731 held (−9%) $25.72 $237K +93.4%
May 20SEC HTFLHeartflow, Inc. Sell Plan 9,21978,731 held (−10%) $28.34 $261K +75.5%
Apr 3SEC HTFLHeartflow, Inc. Sell Plan 64,53381,002 held (−44%) $24.64 $1.6M +101.9%
Mar 23SEC HTFLHeartflow, Inc. Sell Plan 64,53378,518 held (−45%) $25.69 $1.7M +93.6%
Feb 17SEC HTFLHeartflow, Inc. Sell Plan 65,15376,034 held (−46%) $24.49 $1.6M +103.1%
  • Sell

    Chief Medical Officer Campbell Rogers sold $987K of HTFL at $50.15 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Campbell Rogers sold $380K of HTFL at $41.23 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Campbell Rogers sold $237K of HTFL at $25.72 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Campbell Rogers sold $261K of HTFL at $28.34 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Campbell Rogers sold $1.6M of HTFL at $24.64 — cuts the stake by 44%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Campbell Rogers sold $1.7M of HTFL at $25.69 — cuts the stake by 45%; pre-scheduled 10b5-1 plan sale.